XTANDI Reviews (ENZALUTAMIDE)Average Rating: 2.5 (4 Ratings)Filter ResultsCompare XTANDI with similar:
Type: Rx Drug
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR XTANDI | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
1 | Prostate CA | Extreme tiredness and lassitude. Couldn't get out of bed several times. Dry mouth and altered taste of food and beverages. | Was put on this medication as my PSA was rising. This drug is truly awful, making it made me into a zombie with no energy to get out of bed several times. or do minimal tasks around the house. Killed my appetite producing a most unpleasant tast and dryness in my mouth. I stopped it and won't go back on it no matter what. | M | 85 | 1 months 160 1X day | 3/14/2024 | 3 | Prostate Cancer | onset Insomnia is hell when taking 4 tabs a day got better when i reduced the dose. | M | 68 | 3 months 30 1X day | 10/19/2023 | 5 | castrate resistant prostate cancer | 69 | 160 mg 1X day | 7/17/2021 Patient History | 1 | Prostate cancer | Piece of crap drug it does not work. Junk drug and a big ripoff | The drug does not work piece of crap. Got off the drug and my psa went down | M | 72 | 100 days 160 mg 1X day | 10/28/2020 |
XTANDI (ENZALUTAMIDE): Enzalutamide is used to treat men with a certain type of prostate cancer. This type of prostate cancer has not responded to other treatments to lower the male hormone testosterone. This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. FDA Approval Date: 2012-08-31 (Sources: U.S. Centers for Medicare Services, FDA)